Data / Form D filings / Altea Therapeutics Corp
Altea Therapeutics Corp: Form D filings
Altea Therapeutics Corp, a biotechnology company in Atlanta, GA, filed 2 Form D notices with the SEC between 2009 and 2010. The latest, on October 25, 2010, reports $685,000 sold of a $685,000 offering to 8 investors.
Find out what Altea Therapeutics Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 387 TECHNOLOGY CIRCLE NW, Suite 100, Atlanta, GA, 30013
- Phone
- (404) 835-6310
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1310392
The full lists. Form D filings in Georgia: 1,337 rows, $66.85, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 25, 2010 | New notice | $685,000 | $685,000 | $0 | 8 | Oct 14, 2010 | sec.gov |
| May 13, 2009 | New notice | $3,000,000 | $3,000,000 | $0 | 0 | May 1, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric Tomlinson | Executive Officer, Director | |
| Frank Tagliaferri | Executive Officer | |
| Steven Damon | Executive Officer | |
| Anthony Evnin | Director | |
| Ruth Devenyns | Director | |
| Jesse Treu | Director | |
| William Good | Director | |
| Paul Tierney | Director | |
| Alan Smith | Executive Officer | |
| Angela Walsh | Director | |
| Deborah Eppstein | Director |
Other biotechnology companies in Georgia that filed recently
- Opus Medical Therapies, LLC $485,089 · Sep 22, 2026
- Airway Therapeutics, Inc. $43.5 million · Sep 9, 2026
- FEMASYS INC $30 million · Aug 20, 2026
Every Form D from the week of Oct 25, 2010 · All recent filings in Georgia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Altea Therapeutics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.